Home Medizin EHRA 2024 erforscht die Prävention und Behandlung von Herzrhythmusstörungen

EHRA 2024 erforscht die Prävention und Behandlung von Herzrhythmusstörungen

von NFI Redaktion

EHRA 2024: April 7th to 9th in Berlin, Germany and Online

Experience the latest scientific advancements in the prevention and treatment of heart rhythm disorders at EHRA 2024, a scientific congress hosted by the European Society of Cardiology (ESC). The annual congress of the European Heart Rhythm Association (EHRA), a branch of ESC, will take place from April 7th to 9th at CityCube Berlin, Germany, and online. Explore the scientific program.

Be prepared to discover cutting-edge research on new devices and techniques for atrial fibrillation, ventricular fibrillation, and sinus node disorders. Explore over 900 abstracts presenting novel research findings in the field of heart rhythm disorders.

With more than 120 scientific sessions, the latest topics in the field will be presented. Sustainability will be the focus of two sessions, exploring whether remote heart monitoring can reduce greenhouse gas emissions, when pacemakers should be resterilized and re-implanted, and the ethical implications of not reusing catheters and heart devices. Professor Serge Boveda, Chair of the Scientific Program Committee, stated: „The treatment of arrhythmias offers numerous opportunities for environmentally friendly practices, such as local device manufacturing to shorten transport distances, minimizing packaging, and reusing catheters. As we reduce our CO2 footprint for the well-being of all, we can save resources and treat more patients at affordable costs.“

Robotics is an emerging field, and experts will discuss their use in treating complex arrhythmias in congenital heart defects, as well as randomized studies comparing robotic technology with conventional ablation. Professor Jose Luis Merino, President of EHRA, mentioned: „Robotics will play a significant role in electrophysiology. Early robotic systems were bulky, complex, and expensive, but that is changing with newer generations. Ideally, robotization will improve procedure reproducibility and allow us to treat more patients.“

AI Update: Several sessions will examine the pros and cons of AI for predicting atrial fibrillation, stroke, sudden cardiac death, and personalized diagnosis and therapy.

New AI-based tools are expected to help us more accurately predict who will develop arrhythmias, remotely and virtually monitor large cohorts of patients with heart rhythm disorders, and better understand the mechanisms of arrhythmias to improve treatments. AI has the potential to streamline workflows by automating tasks and eliminating the potential for human error.

Professor Andrea Sarkozy, Chair of the Scientific Program Committee

Also on the agenda: sudden cardiac death. Leading experts in this field will explore how sudden cardiac arrest can be prevented in young athletes, the role of genetic testing in pre-participation screening, whether recreational athletes should undergo preventive screening, and how families cope with sudden death. „The way forward is better screening and widespread use of external defibrillators in stadiums and sports halls,“ said Professor Boveda. „Most athletes now survive cardiac arrest because they can be promptly revived. Systematic evaluation of family members is essential to assess their heart rhythm risk. In the future, AI could play a role in identifying recurring patterns associated with these events.“

Don’t miss: challenging decisions in patients with cancer and heart rhythm disorders. „Current questions include the feasibility of radiation therapy against cancer in patients with an implantable heart device,“ said Professor Merino. „Cancer patients have an increased risk of bleeding, and there have been concerns about the use of anticoagulants for treating heart rhythm disorders, but studies have shown that the benefits outweigh the risks. We also need greater awareness of the compatibility of magnetic resonance imaging (MRI) with heart devices so that cancer patients do not miss important tests.“

The theme of EHRA 2024 is „Innovation and Education to Overcome Heart Rhythm Disorders.“ For the first time, a new edition of an international consensus statement on surgical ablation and catheter ablation by EHRA and other scientific societies will be presented, changing the landscape of atrial fibrillation treatment.

The EHRA Innovation Forum will showcase innovations in pacing and arrhythmia monitoring, mapping and imaging, ablation technology, and more. Professor Sarkozy said: „Electrophysiologists are innovators, and the advent of AI is accelerating progress. We expect to hear about cutting-edge non-invasive systems to support screening, groundbreaking means for heart stimulation and defibrillation, and state-of-the-art arrhythmia ablation systems that are more precise and effective than traditional methods.“

The EHRA Congress brings together scientists, healthcare professionals, and key opinion leaders from around the world focused on arrhythmia management. Register now as press to participate in EHRA2024 and receive press releases from the leading arrhythmia meeting in Europe.


European Society of Cardiology (ESC)

Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.